About Us

A Safer Path to Medical Imaging

We’re Redefining What MRI Safety Means

Inventure is a biotechnology company pioneering safer MRI diagnostics through chemical innovation.

Our proprietary Dynamic Equilibrium Stabilization (DES) process enhances the stability of established contrast agents, creating a new class of ultra-stable formulations that deliver diagnostic precision with dramatically improved safety. By building on proven chemistry, we’re advancing MRI safety without disrupting clinical workflows or established medical standards.

The Problem with Conventional Contrast Agents

The Unseen Risks of Retention

Traditional MRI contrast agents rely on gadolinium ions bound within molecular cages.

GBCAs are generally considered extremely stable, based on their thermodynamic stability constants. Without getting too technical, Inventure’s research shows that there is an equilibrium that exists between weak and strong cages. Weak cages are more prone to releasing gadolinium after injection, which can lead to trace amounts depositing in tissues. While, “strong cages” keep the gadolinium securely bound, allowing nearly all of the agent to be cleared by the kidneys within about 12 hours in individuals with normal kidney function.

Over time, certain molecular cages can be challenged upon injection, allowing small amounts of gadolinium to escape and accumulate in the brain, bones, and organs—especially with repeat imaging. Regulators around the world have responded with new guidance and restrictions, highlighting the urgent need for a safer alternative that doesn’t compromise diagnostic performance.

Quarantine if you think you've been exposed

People in quarantine should stay home, separate themselves from others, monitor their health, and follow directions from their state or local health department.
Our Breakthrough

A New Approach to MRI Safety

Inventure’s DES technology redefines how MRI contrast agents are stabilized. Rather than introducing unfamiliar chemistry, we reinforce existing macrocyclic structures—making them significantly more resistant to gadolinium release while preserving the dose, workflow, and diagnostic clarity clinicians already trust.

This balance between innovation and practicality positions GADZero Ultra as the next evolution of contrast safety.

From Laboratory to Clinical Value

Improving Access to Safer Imaging

By increasing stability within proven agents, Inventure’s formulations support safer, repeatable contrast imaging for more patients and broader clinical use.

Our goal is to empower radiologists and healthcare systems with solutions that elevate safety standards while maintaining diagnostic excellence across every scan.

Our Commitment to Science and Safety

Driven by Chemistry. Guided by Care.

At Inventure, we believe meaningful innovation fits seamlessly into medical practice. Our mission is to redefine MRI safety worldwide—creating ultra-stable, accessible contrast agents that protect patients while preserving the clarity physicians rely on. By uniting science and compassion, we’re shaping a future where every contrast-enhanced MRI can be performed with total confidence.